Sign in

Alan Chiu

@chiuonscience.bsky.social
271 followers 132 following 19 posts

Scientist interested in diabetes (especially Type 1), organoids, islets, oncology, and tissue engineering … also unhealthy devoted to the Oscar campaigns of actresses Views are my own and do not represent BreakthroughT1D

PostsRepliesMedia
Alan Chiu @chiuonscience.bsky.social · 16/04/2026
The Tribeca Film Festival slate was just released and it's absolutely STACKED this year ... so much for being financially responsible this month :p
000
Alan Chiu @chiuonscience.bsky.social · 04/04/2026
lol my take that #TheDrama is wildly romantic is going to go over as well as when I argued The Shape of Water was the most beautiful love story of 2017
000
Alan Chiu @chiuonscience.bsky.social · 30/03/2026
I really don’t understand how the MTA has no effective systems in place so that minor issues like someone needing help on a train doesn’t snarl rush hour trains for hours … genuinely why are we so much worse at this than everyone else
000
Alan Chiu @chiuonscience.bsky.social · 29/03/2026
The audible gasp I gave when Ryan Gosling puts two tubes next to each other in the centrifuge in Project Hail Mary lol Hollywood studios!! I’m available as a science consultant!! I’ll even show your actors how to use a pipette!
000
Alan Chiu @chiuonscience.bsky.social · 06/05/2025
Several BreakthroughT1D funding opportunities available 1) Advancing GRS, especially in non-European backgrounds 2) Early detection in adult-onset T1D 3) Tech for scaling manufactured islets Feel free to reach out with questions. Open to industry and academia #funding #grants #T1D
breakthrought1d.org
Type 1 Diabetes Funding Opportunities - Breakthrough T1D
Explore Breakthrough T1D’s funding opportunities for type 1 diabetes research. Learn how we support innovative projects driving breakthroughs in T1D treatment, prevention, and cures.
031
Reposted by Alan Chiu
Alejandra Tomas @tomaslab-imperial.bsky.social · 15/02/2025
Are you interested in developing a research programme in cell biology of diabetes? Do you work in pancreatic islets and/or other metabolically relevant cells? We have a Lectureship post opening in our Section @imperialcollegeldn.bsky.social Apply by 25th March: www.imperial.ac.uk/jobs/search-...
imperial.ac.uk
Description
Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities ment...
0811
Alan Chiu @chiuonscience.bsky.social · 15/12/2024
Listening to my academic friends tell me all about their plans to write and be productive during their sabbaticals knowing full well that if I was ever given one I’d used it to binge watch all 47 seasons of survivor chronologically
000
Alan Chiu @chiuonscience.bsky.social · 05/12/2024
Cool advancements! The biggest obstacle for use is still how long it takes to image these things, even using an Operetta it would take me more than a full day to image 96 well plates before with how many stacks were needed for sufficient resolution.
010
Alan Chiu @chiuonscience.bsky.social · 03/12/2024
How cool, the Clevers lab able to generate fetal pancreatic organoids with all 3 lineages including insulin+ endocrine cells. Will be a really powerful tool for understanding and modeling pancreatic development and dysfunction.
cell.com
Long-term in vitro expansion of a human fetal pancreas stem cell that generates all three pancreatic cell lineages
Identification of an LGR5 as a marker for a tripotent stem/progenitor cell of the human fetal pancreas. Organoids derived from single LGR5+ cells are capable of long-term expansion in vitro and genera...
021
Alan Chiu @chiuonscience.bsky.social · 29/11/2024
Really encouraging results! T1D patients on tirzepatide lost an average of 10% of their bw without an increase in DKA or severe hypoglycemic events … looking forward to future studies with readouts on its effect on CVD www.sciencedirect.com/science/arti...
sciencedirect.com
Effect of Tirzepatide on Body Weight and Diabetes Control in Adults With Type 1 Diabetes and Overweight or Obesity
To determine the effect of tirzepatide on weight, diabetes control, and insulin requirements, and its safety profile in adults with type 1 diabetes (T…
000
Alan Chiu @chiuonscience.bsky.social · 27/11/2024
Really interesting read! To me, vascularization of grafts is the least developed aspect of islet transplantation and studies like this are helpful for understanding what exactly is it we're trying to build
041
Reposted by Alan Chiu
Dr. Jeffrey Millman @jeffreymillman.bsky.social · 25/11/2024
Stem cell-derived islets engineered to express EGFRt were targeted by CAR-Treg cells to suppress innate and adaptive immune responses, which may prevent immune rejection for #T1D cell therapy. Congrats to the Ferreira and Russ teams! www.cell.com/cell-reports... #regenerativemedicine
0133
Alan Chiu @chiuonscience.bsky.social · 25/11/2024
Really interesting ... maybe it will help with the shaming (often from medical professionals) of women who struggle to produce enough if there is an additional alternative to formula
020
Reposted by Alan Chiu
Heiko Lickert @heikolickert.bsky.social · 25/11/2024
Thrilled to share one of our biggest discoveries: “Inceptor binds to and directs insulin towards lysosomal degradation in beta cells”. doi.org/10.1038/s422... A tremendous collaborative effort led by JohannaSiehler, Sara Bilekova and other members of the Lickert lab @heikolickert.bsky.social
doi.org
Inceptor binds to and directs insulin towards lysosomal degradation in β cells - Nature Metabolism
The insulin inhibitory receptor (inceptor) is found to bind to insulin and to regulate insulin stores by directing proinsulin and insulin towards lysosomal degradation.
613053
Reposted by Alan Chiu
Juan Melero-Martin @meleromartinlab.bsky.social · 24/11/2024
Check out this fantastic work by our lab alumnus Kai Wang: Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery. Now out in Cell Stem Cell www.cell.com/cell-stem-ce...
cell.com
Generation of iPSC-derived human venous endothelial cells for the modeling of vascular malformations and drug discovery
Pan et al. generate lineage-specific venous endothelial cells with a heterozygous TIE2-mutation from human iPSCs to recapitulate venous malformations in vitro and in vivo. Deep learning combined with ...
0142
Reposted by Alan Chiu
Prof Claire Hills @chillslincoln79.bsky.social · 21/11/2024
Great to see this update by Kidney Research UK on all things #Diabetic #Kidneydisease in 2024. Special thanks for highlighting the work of our #PhD student Paige on targetting cell senescence in diabetic nephropathy 👩‍🔬🥼🧪..Full details 👇👇 #NephSky #diabetes www.kidneyresearchuk.org/2024/10/24/d...
kidneyresearchuk.org
Diabetes and kidney disease: progress in 2024 - Kidney Research UK
From research to workshops with the diabetes community, progress is being made to prevent the progress of diabetes to kidney disease
1147
Alan Chiu @chiuonscience.bsky.social · 23/11/2024
Wow not sure if it was just the gays behind us yas-ing every 15 seconds but the Wicked movie was kind of … incredible? Also no one sang along!!! I’m sorry I doubted you Times Square AMC, it just felt like you’d be likely to attract people who wouldn’t be able to contain themselves
000
Alan Chiu @chiuonscience.bsky.social · 21/11/2024
Actually maybe the sign of mainstreaming is when Greys Anatomy does a CAR T centric episode
010
Alan Chiu @chiuonscience.bsky.social · 20/11/2024
Cell therapy manufacturing hubs like the one being built on Long Island are going to be huge for access (and economically) as CAR-T and other treatments expand beyond oncology and become more mainstream, especially as the hypoimmune CAR-T efforts seem to be struggling
000
Reposted by Alan Chiu
Omer Dushek @tcell.bsky.social · 20/11/2024
Our new work! We show that T cell cross-reactivity can be reduced without modifying the TCR itself (by dramatically enhancing antigen discrimination). Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors www.biorxiv.org/content/10.1...
Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors
48523
Alan Chiu @chiuonscience.bsky.social · 19/11/2024
⭐💸 Funding Opps 💸⭐ Two new calls from BreakthroughT1D The first is for advancing technologies that support engraftment of transplants The second looks at common mechanisms for autoimmune disease Feel free to reach out with questions #funding #t1d #grants www.breakthrought1d.org/explore-rese...
breakthrought1d.org
Funding Opportunities - Breakthrough T1D
Grant handbook A comprehensive collection of Breakthrough T1D’s grant mechanisms and descriptions; application guidelines and checklists; administrative resources; terms and conditions (updated July 2...
030
Reposted by Alan Chiu
Prof Paul E Squires @paulsquires.bsky.social · 17/11/2024
Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT Trials 👇👇👨‍🔬🧪🥼 #cardiacsky #nephsky #medsky #cardiovascular #kidneydisease #Type2diabetes #semaglutide www.ajkd.org/article/S027...
ajkd.org
DEFINE_ME
1236
Alan Chiu @chiuonscience.bsky.social · 18/11/2024
One of my favorite things about these early BlueSky days is getting recommended posts like this and discovering entire fields of science I didn’t even know existed/had a name
020
Alan Chiu @chiuonscience.bsky.social · 17/11/2024
I set up a calendar reminder to buy I’m Still Here tickets weeks ago but then was too distracted by talks at AHA and forgot to buy them and now they’re sold out 😭😭😭😭
000
Alan Chiu @chiuonscience.bsky.social · 17/11/2024
Another exciting trial result for GLP-1s (tirzepatide), this time for HFpEF Add that to the growing list of secondary benefits it could have for T1D patients as an adjuvant to insulin www.nejm.org/doi/full/10....
nejm.org
Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity | NEJM
Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor...
110
Alan Chiu @chiuonscience.bsky.social · 17/11/2024
Looking forward to reconnecting with the science community (and the nice sections of the film community :p ) on this app I'm also here at #AHA2024 exploring therapies for the T1D community if anyone has insights they'd like to share!
000